RecruitingPhase 3NCT07481981
Respiratory
Heritable pulmonary arterial hypertension
117
studies recruiting now
as of 7 Sept 2026
1,031
studies registered in total
as of 7 Sept 2026
16
countries with a recruiting site
as of 7 Sept 2026
29 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07613099
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
RecruitingPhase 3NCT07365332
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RecruitingNot applicableNCT04194632
Right Ventricular Pacing in Pulmonary Arterial Hypertension
RecruitingNCT00081523
Natural History of Sickle Cell Disease
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 117 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Heritable pulmonary arterial hypertension study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Heritable pulmonary arterial hypertension
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (ATP13A3, ACVRL1, BMPR2, TBX4, ENG, CAV1).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).